VANI vs. OM, CATX, NNOX, CLPT, NPCE, SNWV, RXST, STIM, NYXH, and DRTS
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Outset Medical (OM), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Sanuwave Health (SNWV), RxSight (RXST), Neuronetics (STIM), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.
Vivani Medical vs. Its Competitors
Outset Medical (NASDAQ:OM) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.
Vivani Medical has lower revenue, but higher earnings than Outset Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Outset Medical had 1 more articles in the media than Vivani Medical. MarketBeat recorded 2 mentions for Outset Medical and 1 mentions for Vivani Medical. Outset Medical's average media sentiment score of 1.72 beat Vivani Medical's score of 0.67 indicating that Outset Medical is being referred to more favorably in the media.
6.8% of Vivani Medical shares are held by institutional investors. 2.4% of Outset Medical shares are held by company insiders. Comparatively, 46.4% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Outset Medical has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.89, indicating that its stock price is 189% more volatile than the S&P 500.
Vivani Medical has a net margin of 0.00% compared to Outset Medical's net margin of -98.74%. Vivani Medical's return on equity of -133.07% beat Outset Medical's return on equity.
Outset Medical presently has a consensus price target of $29.50, suggesting a potential upside of 51.75%. Vivani Medical has a consensus price target of $4.00, suggesting a potential upside of 154.78%. Given Vivani Medical's higher probable upside, analysts clearly believe Vivani Medical is more favorable than Outset Medical.
Summary
Vivani Medical beats Outset Medical on 8 of the 15 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 7/24/2025 by MarketBeat.com Staff
